Edgewise Therapeutics Inc

Edgewise Therapeutics insider trading by CMO Donovan Joanne M. shows a mix of large buys at low prices and quick sales, hinting at strong confidence amid rapid biotech growth.

Edgewise Therapeutics insider buying shows CMO confidence in its dystrophy and cardiac pipeline; investors should watch upcoming trials and new insider moves.

Edgewise Therapeutics insider trades reveal a strategic mix of high‑price sales and deep‑discount purchases, suggesting confidence in long‑term biotech value amid market volatility.